🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to explore the efficacy and safety of lanreotide Autogel® 1...
Status
Completed
Location
Erasme Hospital
Start Date
2015-12-15
Trial ID
NCT02651987
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety and patient acc...
Status
Completed
Location
Westmead Hospital
Start Date
2004-06
Trial ID
NCT00216398
Treatments Being Tested
Circulating tumour cells (CTCs) are detectable in the blood in around 50% o...
Status
Completed
Location
Basingstoke & North Hampshire Hospital
Start Date
2014-05
Trial ID
NCT02075606
Treatments Being Tested
The main aim of this study is to assess the Progression-Free Survival (PFS)...
Status
Withdrawn
Location
Uniwersyteckie Centrum Kliniczne
Start Date
2019-08
Trial ID
NCT03895463
The aim of the study is to identify predictive factors for the response to ...
Status
Completed
Location
University Hospital of Vienna
Start Date
2012-06
Trial ID
NCT01840449
Treatments Being Tested
This is a Phase 3, prospective, multi-center, randomized, double-blind, stu...
Status
Terminated
Location
Arizona Oncology Associates
Start Date
2017-03-06
Trial ID
NCT02683941
Treatments Being Tested
Lanreotide Autogel® has been established as a standard of care for patients...
Status
Completed
Location
Changhoon Yoo
Start Date
2021-01-01
Trial ID
NCT04696042
Treatments Being Tested
The purpose of this study, is to assess the safety and local tolerability o...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2008-07
Trial ID
NCT00747500
The aim of the study is to generate real-world evidence to describe the pat...
Status
Completed
Location
University Hospitals Birmingham NHS Foundation Trust
Start Date
2021-04-27
Trial ID
NCT04649580
Background Somatostatin and octreotide LAR (long-acting analogue) exert a n...
Status
Unknown
Location
UMC St. Radboud Medical Center
Start Date
2007-10
Trial ID
NCT00543179
Treatments Being Tested